Desk›Services› Genpharmasec Ltd
Genpharmasec Ltd
BSE 531592 · NSE GENPHARMA · ISIN INE861N01036 · Group X · Active
Services › Services › Commercial Services & Supplies › Trading & Distributors
₹1.00
+0.00%
BSE close, 28 August 2026
₹55.37 cr
55.4 cr shares · Micro cap
₹38.77 cr
as published
10.0× · 0.83×
EPS ₹0.10 · BV ₹1.20
131.35 / 5.45
₹ cr, as filed
18
5 selected · 28%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -53.5% |
|---|---|
| Against 52-week low | +33.3% |
| Day change | +0.00% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹0.10 |
|---|---|
| Price / earnings | 10.00× |
| Price / book | 0.83× |
| Book value — derived, price ÷ P/B | ₹1.20 |
| Return on equity | 8.24% |
| Operating margin | 5.18% |
| Net margin | 3.51% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 8.30%
- ROE as published
- 8.24%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 44.78 | 1.57 | 0.03 | 5.18% | 3.51% |
| Mar-26 · Q | 51.66 | 2.32 | 0.04 | 6.20% | 4.49% |
| FY25-26 | 131.35 | 5.45 | 0.10 | 5.55% | 4.15% |
Quarter on quarter
- Revenue, quarter on quarter
- -13.3%
- Net profit, quarter on quarter
- -32.3%
- Operating margin, quarter on quarter
- -102 bps
Disclosure profile 18 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 2 |
| Change in Management | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| AGM / EGM | 3 |
| Board Meeting | 2 |
| Newspaper Publication | 2 |
| SAST | 2 |
| Annual Report | 1 |
| Book Closure | 1 |
| Compliance Certificate | 1 |
| Other Update | 1 |
| Procedural sub-total | 13 |
| Total | 18 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
18 filings · 5 selected · busiest 2026-09-02
Filing rhythm · the twelve most recent
2026-08-282026-10-05
SelectedProcedural
Filings
18 in the window · 2 earlier on record
-
5 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Disclosure of Voting Results and Scrutinizers report of the 34th Annual General Meeting held on 29th September, 2026.
AGM/EGM / AGM View filing →
-
29 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Submission of Proceeding of the 34th Annual General Meeting of the Member of the Genpharmasec Ltd held on Tuesday, 29th September, 2026.
AGM/EGM / AGM View filing →
-
8 September 2026 ·
Newspaper Publication
Newspaper Publication of Notice of AGM to be held on 29th September, 2026.
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for Financial Year 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
7 September 2026 ·
Notice Of The 34Th Annual General Meeting Of The Company To Be Held On September 29, 2026.
Notice of 34th Annual General Meeting of the company to be held on September 29, 2026.
AGM/EGM / AGM View filing →
-
2 September 2026 ·
Intimation Of Book Closure For The Purpose Of AGM
Intimation of Book Closure for AGM to be held on 29th September, 2026.
Corp. Action / Book Closure View filing →
-
2 September 2026 ·
Change in Management
Outcome of the Meeting of Board of Directors held on Wednesday, 02nd September, 2026.
Company Update / Change in Management View filing →
-
2 September 2026 ·
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Wednesday, 02Nd September, 2026.
Outcome of the Meeting of Board of Directors held on Wednesday, 02nd September, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
2 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Sadhwani & PACs
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
31 August 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Sadhwani
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
28 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, 02Nd September, 2026.
Genpharmasec Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve 1. To Fix the Day, Date, Time ....
Board Meeting / Board Meeting View filing →
-
13 August 2026 ·
Press Release / Media Release
Regarding Recent Agreement with Amneal Healthcare Private Limited
Company Update / Press Release / Media Release View filing →
-
13 August 2026 ·
Newspaper Publication
Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026.
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2026.
Statement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th June, 2026.
Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
-
11 August 2026 ·
Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2026.
Unaudited Standalone & Consolidated Financial Results of the company for the quarter ended 30th June, 2026.
Result / Financial Results View filing →
-
11 August 2026 ·
Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, 11Th August, 2026.
Outcome of the Meeting of Board of Directors held on Tuesday, 11th August, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
3 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 11Th August, 2026.
Genpharmasec Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-audited ....
Board Meeting / Board Meeting View filing →
RSS feed for Genpharmasec Ltd · the 50 most recent filings